HCV-associated hepatocellular carcinoma without cirrhosis

Journal of Hepatology

Volumn 24, Issue 3, 1996, Pages 277-285

  El Refaie, Amany ^a,b   Savage, Kay ^a   Bhattacharya, Satyajit ^a   Khakoo, Salim ^a   Harrison, Tim J ^a   El Batanony, Mohamed ^a,b   Soliman, El Sayed ^c   Nasr, Safaa ^d   Mokhtar, Nadia ^e   Amer, Kawther ^b   Scheuer, Peter J ^a   Dhillon, Amar Paul ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b MENOUFIA UNIVERSITY   (Egypt)

^c MENOUFIA UNIVERSITY   (Egypt)

^d CAIRO UNIVERSITY   (Egypt)

^e CAIRO UNIVERSITY   (Egypt)

Author keywords

alpha 1 antitrypsin; HBV DNA; HCV RNA; polymerase chain reaction; primary liver tumors

Indexed keywords

ALPHA 1 ANTITRYPSIN; VIRUS DNA; VIRUS RNA;

ADULT; AGAR GEL ELECTROPHORESIS; AGED; ARTICLE; CARCINOGENESIS; CASE REPORT; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEPATITIS C; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER REGENERATION; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS GENOME;

EID: 0029919487     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(96)80005-5     Document Type: Article

References (41)

1. Parkin DM, Stjernsward J, Muir CS. Estimates of the worldwide frequency of twelve major cancers. Bull World Health Organ 1984; 62: 163-8.
2. Okuda K, Ohnishi K. Prognosis of hepatocellular carcinoma. In: Okuda K, Ishak KG eds. Neoplasms of the Liver. Tokyo: Springer-Verlag, 1987; 407-16.
3. Waterhouse J, Muir C, Shnmugaratnam K, Powell J. Cancer Incidence in Five Continents, vol. IV. Lyon: IARC Scientific Publications 1982; 42: 714-5.
4. Colombo M. Hepatocellular carcinoma. J Hepatol 1992; 15: 225-36.
5. Feitelson M. Hepatitis B virus infection and primary hepatocellular carcinoma. Clin Microbiol Rev 1992; 5: 275-301.
6. Buendia AM. Mammalian hepatitis B viruses and primary liver cancer. Semin Cancer Biol 1992; 3: 309-20.
7. Paterlini P, Gerken G, Nakajima E, Terre S, D'Errico A, Grigioni B, Nalpas B, Franco D, Wands J, Kew M, Pisi E, Tiollais P, Bréchot C. Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen. N Engl J Med 1990; 323: 80-5.
8. Liang TJ, Baruch Y, Ben-Porath E, Enat R, Bassan L, Brown NV. Hepatitis B virus infection in patients with idiopathic liver disease. Hepatology 1991; 13: 1044-51.
9. Diamantis ID, McGandy CE, Pult I, Buhler H, Schmid M, Gudat F, Bianchi L. Polymerase chain reaction detects hepatitis B virus DNA in paraffin-embedded liver tissue from patients sero-and histo-negative for active hepatitis B. Virchows Archiv A Pathol Anat 1992; 420: 11-5.
10. Paterlini P, Driss F, Nalpas B, Pisi E, Franco D, Berthelot P, Brechot C. Persistence of hepatitis B and hepatitis C viral genomes in primary liver cancer from HBsAg-negative patients: a study of a low-endemic area. Hepatology 1993; 17: 20-9.
11. Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y. Furuta S, Akahane Y, Nishioka K, Purcell RH. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 1990; 12: 671-75.
12. Bruix J, Barrera JM, Catvet X, Ercella G, Costa J, Sanchez-Tapias JM, Ventura M, Vall M, Bruguera M, Bru C, Castillo R, Rodes J. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet 1989; ii: 1004-6.
13. Colombo M, Choo L, Donato MF, Del Ninno E, Tommasini MA, Dioguardi N, Houghton M. Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet 1989; ii: 1006-8.
14. Tsukuma H, Hiyama T, Tanaka S, Nakao M, Yabuuchi T, Kitamura T, Nakanishi K, Fujimto I, Inoue A, Yamazaki H, Kawashima T. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 1993; 328: 1797-801.
15. Gerber MA. Relation of hepatitis C virus to hepatocellular carcinoma. J Hepatol 1993; 17 (Suppl. 3): S108-S111.
16. Gentilini P, Melani L, Riccardi D, Raggi V, Romanelli R. Hepatocellular carcinoma and viral cirrhosis. Hepatology 1994; 20: 764-5.
17. Kew MC. Hepatocellular carcinoma with and without cirrhosis. A comparison in Southern African Blacks. Gastroenterology 1989; 97: 136-9.
18. Anthony PP. Tumours and tumour-like lesions of the liver and biliary tract. In: MacSween RNM, Anthony PP, Scheuer PJ, Portman BC, Burt AD, eds. Pathology of the Liver, 3rd Edit. Edinburgh: Churchill Livingstone, 1995; 652-3.
19. Okuda K, Nakashima T, Kojiro M, Kondo Y, Wada K. Hepatocellular carcinoma without cirrhosis in Japanese patients. Gastroenterology 1989; 97: 140-6.
20. Kew MC. Tumours of the liver. Scand J Gastroenterol 1992; 27(Suppl. 192): 39-42.
21. Sternberger LA, Hardy PH, Cuculis JJ, Meyer HG. The unlabelled antibody-enzyme method of immunohistochemistry. Preparation and properties of soluble antigen-antibody complex (horseradish peroxidase-antihorseradish peroxidase) and its use in identification of spirochetes. J Histochem Cytochem 1970; 18: 315-33.
22. El-Batanony M, Savage K, Jacobs R, El-Refaie A, Squadrito G, Brown D, Saleh SM, Raouff AA, Amer KM, Dusheiko GM, Scheuer PJ, Dhillon AP. Hepatitis C virus-polymerase chain reaction of routinely processed liver biopsies. J Med Virol 1994; 43: 380-5.
23. Fagan EA, Harrison TJ. Exclusion in the liver by polymerase chain reaction of hepatitis B and C viruses in acute liver failure attributed to sporadic non-A, non-B hepatitis. J Hepatol 1994; 21: 587-91.
24. Lo M, Lo ES, Mehal WZ, Sampietro M, Fiorelli G, Ronchi G, Tse CH, Fleming KA. Geographical variation in prevalence of hepatitis B virus DNA in HBsAg negative patients. J Clin Pathol 1993; 46: 304-8.
25. Kwok S, Higuchi R. Avoiding false positives with PCR. Nature 1989; 339: 237-8.
26. Schirmacher P, Rogler CE, Dienes HP. Current pathogenetic and molecular concepts in viral liver carcinogenesis. Virchows Arch B Cell Pathol 1993; 63: 71-89.
27. Diamantis ID, McGandy CE, Chen T, Liaw Y, Gudat F, Bianchi L. Detection of hepatitis B and C viruses in liver tissue with hepatocellular carcinoma. J Hepatol 1994; 20: 405-9.
28. Takano S, Yokosuka O, Imazeki F, Tagawa M, Omata M. Incidence of hepatocellular carcinoma in chronic hepatitis B and C: a prospective study of 251 patients. Hepatology 1995; 21: 650-5.
29. Simonetti RG, Camma C, Fiorello F, Cottone M, Rapicetta M, Marino L, Fiorenti G, Craxi A, Ciccaglione A, Giuseppetti R, Stroffolini T, Pagliaro L. Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. Ann Intern Med 1992; 116: 97-102.
30. Bruno S, Villa E, Chiesa A, Rossi S, Grottola A, Buttafoco P, Zuin M, Podda M. Persistence of HCV RNA is associated with risk of hepatocellular carcinoma development. Gastroenterology 1993; 104: A881.
31. Muchmore E, Popper H, Peterson DA, Miller MF, Lieberman HM. Non-A, non-B hepatitis-related hepatocellular carcinoma in a chimpanzee. J Med Primatol 1988; 17: 235-46.
32. Herr W, Gerken G, Poralla T, Immenschuh S, Schirmacher P, Steegmuller KW, Schwickert H, Meyer zum Buschenfelde KH. Hepatitis C virus associated primary hepatocellular carcinoma in a noncirrhotic liver. Clin Invest 1993; 71: 49-53.
33. De Mitri MS, Poussin K, Baccarini O, Pontisso P, D'Errico A, Simon N, Grigioni W, Alberti A, Beaugrand M, Pisi E, Brechet C, Paterlini P. HCV-associated liver cancer without cirrhosis. Lancet 1995; 345: 413-5.
34. Rolfes DB. Neoplasms of liver. In: Okuda K, Ishak KG, eds. Neoplasms of the Liver. Tokyo: Springer-Verlag, 1987; 137-42.
35. Sakamuro D, Furukawa T, Takegami T. Hepatitis C virus nonstructural protein NS3 transforms NIH 3T3 cells. J Virol 1995; 69: 3893-6.
36. An SF, Fleming KA. Removal of inhibitors of the polymerase chain reaction from formalin-fixed, paraffin wax-embedded tissues. J Clin Pathol 1991; 44: 924-7.
37. Takada N, Takase S, Enomoto N, Takada A, Date T. Clinical background of the patients having different types of hepatitis C virus genomes. J Hepatol 1992; 14: 35-40.
38. Di Bisceglie A. Hepatitis C and hepatocellular carcinoma. Semin Liver Dis 1995; 15: 64-9.
39. Poley JR. Malignant liver disease in alpha-1-antitrypsin deficiency. Acta Paediatr 1994; Suppl 393: 27-32.
40. 1-antitrypsin deficiency-associated liver disease. J Pediatr Gastroenterol Nutr 1990; 10: 5-12.
41. Crystal RG. Alpha-1-antitrypsin deficiency, emphysema and liver disease. J Clin Invest 1990; 85: 1343-52.